News & Announcements
Date : July 20th 2022
PointCross Life Sciences announced the full complement release of its eDataValidator (eDV) for validating SDTM, ADaM, SEND and Define.XML data for conformance to prevailing FDA, CDISC, and PMDA rules. eDV offers limitless validation of Clinical SDTM as well as Nonclinical SEND, making this a single solution for IND, NDA and BLA preparation
To get started with eDataValidator, please proceed here.
Society of Toxicology
Date and Time: March 29th at 1:30pm PT
San Diego, CA.
PointCross held a panel discussion with senior industry partners at the Society of Toxicology conference in March 2022 discussing the implications of interim study monitoring, including the time and cost savings achievable by having a subject’s in-life, necropsy, and pathology findings available in digital format sooner than the final study report.
More information on Interim Study Monitoring can be found here
PhUSE US Connect
Poster Presentation :
Integrating Clinical Data for Translational Research
PointCross’s Xbiom Clinical Insights Module is designed for Translational Medicine Teams to curate, harmonize, and standardize disparate assay data and EDC study data from clinical trials, along with genotyping data, molecular, and other biomarker data. Our newly launched Data Concierge Service helps shoulder the burden of data wrangling by integrating directly with your CROs and external labs to help close the gap between these disparate data sources and rendering study data fit-for-use by scientists and researchers for longitudinal analysis, cross-domain search, and stratified cohort selection based on patient history, consent availability, specific molecular biomarkers, study type, and more.
Success For Our Valued Customers
We thank our customers for their trust shown in us and take pride in our accomplishments.
US – India – Europe
Our Vision is to standardize and contextually integrate all data collected in discovery or nonclinical and clinical trials, with genomic and immune response data from the patient from their bio-samples or other, to support precision medicine development and translational research to discover treatments for illness and disease.